Streamlined FH Screening: Scaling Early FH Diagnosis for At-Risk Children

Cardiology Innovators are Revolutionizing the Diagnosis of Familial Hypercholesterolemia (FH)

The Vroni Study Team, supported by the Deutsches Herzzentrum München, focuses on identifying children at risk of Familial Hypercholesterolemia (FH), a genetic condition causing dangerously high cholesterol and early-onset cardiovascular disease. Early detection is critical, as undiagnosed FH can lead to life-threatening events later in life.

The study’s vision was to integrate FH screening into routine pediatric check-ups, offering families and clinicians tools for early detection and preventive care.

To achieve this, they needed a partner to streamline workflows, automate data management, and scale the study effectively.

Early Diagnosis of FH in Children is an Urgent Medical Need

Familial Hypercholesterolemia (FH) is a hereditary condition that affects 1 in 250 people, leading to persistently high cholesterol levels and significantly increasing the risk of early-onset cardiovascular disease. In children, FH often remains undetected due to its asymptomatic nature and the lack of routine screening during pediatric visits.

Early FH diagnosis is critical to initiate timely treatment, including lifestyle modifications and medical intervention, to prevent severe complications later in life. However, without systematic screening, most cases of FH are missed during routine check-ups.

The challenge of detecting FH during regular pediatric visits lies in the absence of obvious symptoms and the reliance on traditional, manual methods that are time-consuming and error-prone. This delay in diagnosis can have lifelong health impacts for children, their families, and the healthcare system.

Traditional Workflows Hindered Vroni's Reach to Better Pediatric Health

The initial phase of the Vroni Study faced challenges due to reliance on manual data entry and inefficient workflows in clinics. Pediatricians struggled to incorporate FH screening into their busy routines, while study coordinators spent hours processing paper-based questionnaires. These barriers reduced enrollment rates and limited the study's ability to scale.

To overcome these problems, the Vroni study team envisioned a more efficient approach - automating data collection, streamlining workflows and enabling clinics to seamlessly incorporate FH screening into routine visits.

Their mission was to ensure that every child at risk could be identified and treated early. The goal was to simplify the process for clinics while significantly boosting enrollment and accuracy in FH screening.

So their goal was clear: to turn FH diagnosis into an effortless, integrated part of routine pediatric care. Soon after they met the punktum team.

The Vroni Study Team Needed an Innovative Technology Partner

Faced with inefficiencies in workflows and low enrollment rates, the Vroni Study Team began searching for a partner with expertise in healthcare automation and scalable digital solutions.

After meeting us and having initial discussions, we quickly aligned on their needs and developed a clear plan to address their challenges. Together, we mapped out a roadmap focused on key outcomes: automating data handling, streamlining clinic workflows, and boosting enrollment rates.

Confident in our expertise and collaborative approach, the Vroni Study Team chose to work with us to bring their vision to life.

Our Delivery: An Automated, Scalable Solution for Optimized Pediatric FH Diagnosis

With a clear roadmap in place, we were ready to turn ideas into action. Our focus shifted to delivering practical, impactful solutions tailored to the Vroni Study’s unique challenges:

Deep Research to Understand Needs:
We conducted detailed interviews with pediatricians, nurses, and study coordinators to identify barriers to integrating FH screening into workflows. These discussions revealed critical inefficiencies, such as reliance on manual processes, onboarding challenges, and difficulties in managing patient data effectively.

Validation Through Pilot Testing:
Collaborating with select clinics, we tested the solution in real-world settings. Feedback from healthcare providers helped us refine the tools, ensuring they were both practical and scalable for broader adoption.

These solutions empowered the Vroni Study Team to optimize operations, increase enrollment rates, and focus on identifying at-risk children for early intervention.

Results that Matter: Unlocking Efficiency, Implementing OCR and Scale in FH Diagnosis

The solutions delivered measurable improvements, empowering the Vroni Study Team to streamline operations, increase participation, and scale their efforts effectively.

New Opportunities and Future Potential Thanks to Digital Health Solutions

The Vroni Study is now positioned to scale its efforts and expand its impact on pediatric healthcare. The streamlined workflows and automated tools have unlocked significant possibilities for the study’s future.

Scaling to Additional Clinics:
The team is actively onboarding more pediatric clinics, allowing a greater number of children to benefit from early FH diagnosis and intervention.

Utilizing Advanced Data Insights:
Digitized and accurate data is already being used to analyze trends, refine screening strategies, and enhance FH management approaches.

Setting a New Standard for Pediatric Screening:
The Vroni Study is becoming a model for integrating preventive care into routine pediatric check-ups, driving a shift towards early detection and intervention for hereditary conditions.

What We Think of the Project Outcome?

We are proud to have supported the Vroni Study in its mission to transform early FH diagnosis for children. Improving lives through innovative healthcare solutions is not just our expertise - it’s our commitment. Seeing the impact of these efforts motivates us to continue creating meaningful change in healthcare.

Together with the Vroni Study Team, we’ve made strides toward addressing a silent but critical health risk in children.

This collaboration reinforces the value of combining cutting-edge technology with a clear vision. The Vroni Study is now a model for how pediatric healthcare can embrace innovation to deliver lasting impact.